Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02462863 · ClinicalTrials.gov registry record · NA
Treatment of Type 2 Diabetes With Immunonutrients
A NA study, sponsored by The Christ Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02462863 is a NA study that has completed, run by The Christ Hospital. The registered enrollment target is 6 participants.
The verdict
NCT02462863, a NA study, has completed, sponsored by The Christ Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if the nutrients arginine and fish oil will reverse or improve diabetes and to find out what additional good or bad effects a combination of arginine and fish oil may have. Both arginine and fish oil are common nutrients taken by normal people on a frequent basis. However, they have not been used in combination in the proposed doses to reverse diabetes once it is established. This study has been approved by the Food and Drug Administration (FDA investigational new drug \[IND\] 12191).
Interventions
- DIETARY_SUPPLEMENT Arginine and fish oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2017-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02462863
The ClinicalTrials.gov registry entry for NCT02462863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Christ Hospital, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Arginine and fish oil is the first listed.
NCT02462863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02462863 about?
NCT02462863 is a clinical study titled "Treatment of Type 2 Diabetes With Immunonutrients". The purpose of this research study is to determine if the nutrients arginine and fish oil will reverse or improve diabetes and to find out what additional good or bad effects a combination of arginine and fish oil may have. Both arginine and fish oil are common nutrients taken by normal people on a ...
What is the current status of trial NCT02462863?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-03-01. Estimated completion is 2017-06-07.
What interventions are being tested in trial NCT02462863?
The interventions under investigation include: Arginine and fish oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02462863?
This trial is sponsored by The Christ Hospital, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.